Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
2006-7-3
pubmed:abstractText
Fibroblast growth factor 8 (FGF8) is over-expressed in prostate cancer (CaP) correlating with high-grade disease and reduced survival. The role of acetylation in transcriptional regulation of FGF8 was investigated using the histone deacetylase (HDAC) inhibitor Trichostatin A (TSA).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Chromatin, http://linkedlifedata.com/resource/pubmed/chemical/DNA, http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/FGF8 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Fibroblast Growth Factor 8, http://linkedlifedata.com/resource/pubmed/chemical/Histone Deacetylase Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Hydroxamic Acids, http://linkedlifedata.com/resource/pubmed/chemical/NF-kappa B, http://linkedlifedata.com/resource/pubmed/chemical/Phosphatidylinositol 3-Kinases, http://linkedlifedata.com/resource/pubmed/chemical/RELA protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Fusion Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Transcription Factor RelA, http://linkedlifedata.com/resource/pubmed/chemical/trichostatin A
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0270-4137
pubmed:author
pubmed:copyrightInfo
(c) 2006 Wiley-Liss, Inc.
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
66
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1223-34
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:16683270-Acetylation, pubmed-meshheading:16683270-Base Sequence, pubmed-meshheading:16683270-Binding Sites, pubmed-meshheading:16683270-Blotting, Western, pubmed-meshheading:16683270-Cell Line, Tumor, pubmed-meshheading:16683270-Chromatin, pubmed-meshheading:16683270-DNA, pubmed-meshheading:16683270-Enzyme Inhibitors, pubmed-meshheading:16683270-Fibroblast Growth Factor 8, pubmed-meshheading:16683270-Gene Expression Regulation, Neoplastic, pubmed-meshheading:16683270-Histone Deacetylase Inhibitors, pubmed-meshheading:16683270-Humans, pubmed-meshheading:16683270-Hydroxamic Acids, pubmed-meshheading:16683270-Immunosorbent Techniques, pubmed-meshheading:16683270-Male, pubmed-meshheading:16683270-Molecular Sequence Data, pubmed-meshheading:16683270-NF-kappa B, pubmed-meshheading:16683270-Phosphatidylinositol 3-Kinases, pubmed-meshheading:16683270-Polymerase Chain Reaction, pubmed-meshheading:16683270-Promoter Regions, Genetic, pubmed-meshheading:16683270-Prostatic Neoplasms, pubmed-meshheading:16683270-Recombinant Fusion Proteins, pubmed-meshheading:16683270-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:16683270-Transcription, Genetic, pubmed-meshheading:16683270-Transcription Factor RelA, pubmed-meshheading:16683270-Transfection, pubmed-meshheading:16683270-Up-Regulation
pubmed:year
2006
pubmed:articleTitle
NF-kappaB activation upregulates fibroblast growth factor 8 expression in prostate cancer cells.
pubmed:affiliation
Urology Research Group, Northern Institute for Cancer Research, University of Newcastle upon Tyne, Medical School, Framlington Place, Newcastle upon Tyne, United Kingdom.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't